Ruxolitinib

Catalogue Number: CV-1032-1-RPE

Manufacturer:rPeptide
Physical state:Lyophilized
Type:Kinase Inhibitors
Shipping Condition:RT
Unit(s): 5 mg

Description

Description: Potent and selective JAK1&2 inhibitor, IC50s=2.7, 4.5 and 322 nM for JAK1, JAK2 and JAK3 respectively. Blocks IL-6 signaling (IC50=281 nM) and proliferation of JAK2V617F+ Ba/F3 cells (IC50=127 nM). Inhibits the proinflammatory secretome of senescent cells. The JAK1 S646P mutant is highly sensitive to ruxolitinib. Clinically useful anticancer agent.